MRD / Regn No. : THBC\23-24\02648 Date : 10/06/2026
Patient Name : Mandakini Wayadande Age & Gender : 79 Yrs. / Female
Contact No. : 9820547125 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (26/May/2008) | HTN (16/Jul/2008) |
Subjective : T2DM-15YRS,HTN-15YRS,RETINOPATHY - RECD VEGF INJECTION
Objective : 10-JUN-2026 REPORTS,HB-9.4%,CR-1.52,URIC ACID-8.7,EGFR-35,FBS-66.7/ PPBS-137.27,HBA1C-7.3%
Plan : REDUCING DOSE OF ISRYL FROM 2 MG TO 1 MG - IF FBS < 100 - THEN CAN REDUCE DOSE FURTHER  
S# Generic (Trade) Name Route Dosage Usage Duration
1 ISRYL 2MG ORAL 1-0-0 BBF
4 MTHS
2 TABLET SITAGLIPTIN (50MG)
ISTAVEL 50 MG
ORAL 1-0-1 BBF / BD
4 MTHS
3 UNISTAR 5/75 MG ORAL 0-0-1 AD
4 MTHS
4 DRISE 60,000 ORAL ONCE IN 15 DAYS ANY TIME OF DAY
4 MTHS
5 TABLET RABEPRAZOLE
NEXPRO RD
ORAL 1-0-0 BBF
4 MTHS
6 OLMIN CH 40 MG ORAL 1-0-0 ABF
4 MTHS
7 SHELCAL GUMMIES ORAL 0-1-0 AL / 3 DAYS A WEEK
4 MTHS
8 PIOGLITAZONE 15 MG
PIOZ 15 MG
ORAL 1-0-0 ABF
4 MTHS
9 CAP OROFER XT ORAL 0-1-0 3 DAYS A WEEK
4 MTHS
10 ISRYL 1 MG ORAL 0-0-1 BEFORE DINNER
4 MTHS
11 PRUVICT 1 MG ORAL 0-0-1 AS NEEDED FOR CONSTIPATION
30 DAYS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 10/Jun/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C / RFT > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: